ICDIQ Statistics
Total Valuation
ICDIQ has a market cap or net worth of 414,671. The enterprise value is 179.87 million.
| Market Cap | 414,671 |
| Enterprise Value | 179.87M |
Important Dates
The last earnings date was Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ICDIQ has 15.11 million shares outstanding. The number of shares has increased by 3.69% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 15.11M |
| Shares Change (YoY) | +3.69% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 9.02% |
| Owned by Institutions (%) | 0.58% |
| Float | 9.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | 0.05 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.24, with an EV/FCF ratio of 20.71.
| EV / Earnings | -2.56 |
| EV / Sales | 1.04 |
| EV / EBITDA | 4.24 |
| EV / EBIT | n/a |
| EV / FCF | 20.71 |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 1.32.
| Current Ratio | 0.76 |
| Quick Ratio | 0.68 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | 4.37 |
| Debt / FCF | 21.36 |
| Interest Coverage | -0.40 |
Financial Efficiency
Return on equity (ROE) is -40.49% and return on invested capital (ROIC) is -2.90%.
| Return on Equity (ROE) | -40.49% |
| Return on Assets (ROA) | -2.63% |
| Return on Invested Capital (ROIC) | -2.90% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 386,189 |
| Profits Per Employee | -155,884 |
| Employee Count | 450 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 71.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.68% in the last 52 weeks. The beta is 5.07, so ICDIQ's price volatility has been higher than the market average.
| Beta (5Y) | 5.07 |
| 52-Week Price Change | -98.68% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.78 |
| Relative Strength Index (RSI) | 48.29 |
| Average Volume (20 Days) | 236,504 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, ICDIQ had revenue of 173.79 million and -70.15 million in losses. Loss per share was -4.87.
| Revenue | 173.79M |
| Gross Profit | 50.29M |
| Operating Income | -16.07M |
| Pretax Income | -73.20M |
| Net Income | -70.15M |
| EBITDA | 32.38M |
| EBIT | -16.07M |
| Loss Per Share | -4.87 |
Balance Sheet
The company has 6.08 million in cash and 185.53 million in debt, giving a net cash position of -179.46 million or -11.88 per share.
| Cash & Cash Equivalents | 6.08M |
| Total Debt | 185.53M |
| Net Cash | -179.46M |
| Net Cash Per Share | -11.88 |
| Equity (Book Value) | 140.07M |
| Book Value Per Share | 9.64 |
| Working Capital | -9.49M |
Cash Flow
In the last 12 months, operating cash flow was 36.56 million and capital expenditures -27.88 million, giving a free cash flow of 8.69 million.
| Operating Cash Flow | 36.56M |
| Capital Expenditures | -27.88M |
| Free Cash Flow | 8.69M |
| FCF Per Share | 0.58 |
Margins
Gross margin is 28.94%, with operating and profit margins of -9.24% and -40.36%.
| Gross Margin | 28.94% |
| Operating Margin | -9.24% |
| Pretax Margin | -42.12% |
| Profit Margin | -40.36% |
| EBITDA Margin | 18.63% |
| EBIT Margin | -9.24% |
| FCF Margin | 5.00% |
Dividends & Yields
ICDIQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.69% |
| Shareholder Yield | -3.69% |
| Earnings Yield | -17,739.32% |
| FCF Yield | 2,094.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 12, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Mar 12, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
ICDIQ has an Altman Z-Score of -1.51. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.51 |
| Piotroski F-Score | n/a |